Contact
Please use this form to send email to PR contact of this press release:
Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer
TO:
Please use this form to send email to PR contact of this press release:
Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer
TO: